Trial Profile
Late Phase Administration Anakinra as a Rescue Treatment for Inhaled Allergen Challenge-Induced Airway Inflammation
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I/II
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Anakinra (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms LateAna
- 20 Jul 2020 Status changed from recruiting to withdrawn prior to enrolment.
- 07 May 2020 Planned initiation date (estimated date for recruitment of the first subject) changed from 1 Mar 2020 to 1 Sep 2020.
- 04 Feb 2020 Planned initiation date (estimated date for recruitment of the first subject) changed to 1 Mar 2020.